Cineverse Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Cineverse Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $78.18M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $49.13M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $68.03M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $56.05M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $31.42M | Jul 1, 2022 |
| FY2020 | Mar 31, 2020 | $7.74M | Jul 6, 2020 |
| FY2019 | Mar 31, 2019 | $12.07M | Jul 16, 2019 |
| FY2018 | Mar 31, 2018 | $17.67M | Jun 26, 2018 |
| FY2018 | Mar 31, 2017 | $90.39M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $104.45M | Jun 29, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $78.18M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $49.13M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $68.03M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $56.05M | Jun 29, 2023 |
| FY2021 | Mar 31, 2021 | $600.0K | Jul 30, 2021 |
| FY2021 | Mar 31, 2020 | $1.40M | Jul 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.76M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($21.27M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($9.69M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $2.27M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($62.91M) | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | ($14.73M) | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | ($16.23M) | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | ($18.45M) | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | ($15.13M) | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | ($41.74M) | Jun 29, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $7.92M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($15.70M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($8.92M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($925.0K) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($13.47M) | Jul 1, 2022 |
| FY2020 | Mar 31, 2020 | ($1.17M) | Jul 6, 2020 |
| FY2019 | Mar 31, 2019 | ($3.67M) | Jul 16, 2019 |
| FY2018 | Mar 31, 2018 | $2.99M | Jun 26, 2018 |
| FY2018 | Mar 31, 2017 | $6.76M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | ($21.15M) | Jun 29, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $27.68M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $27.90M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $36.82M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $29.55M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $21.87M | Jul 1, 2022 |
| FY2020 | Mar 31, 2020 | $2.51M | Jul 6, 2020 |
| FY2019 | Mar 31, 2019 | $8.21M | Jul 16, 2019 |
| FY2018 | Mar 31, 2018 | $6.63M | Jun 26, 2018 |
| FY2018 | Mar 31, 2017 | $23.78M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $33.37M | Jun 29, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $17.41M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($10.59M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($8.80M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $4.88M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($20.01M) | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | $7.76M | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | $11.09M | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | $22.40M | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | $31.70M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $25.50M | Jun 29, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Mar 31, 2024 | $1.07M | Jul 1, 2024 |
| FY2024 | Mar 31, 2023 | $1.27M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $316.0K | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $6.49M | Jul 1, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $72.52M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $64.38M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $87.99M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $104.64M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $75.45M | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | $110.44M | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | $98.84M | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | $121.18M | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | $151.33M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $209.40M | Jun 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $34.72M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $32.23M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $48.92M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $63.69M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $59.56M | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | $129.73M | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | $135.41M | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | $143.49M | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | $222.04M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $282.43M | Jun 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $38.75M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $33.27M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $40.34M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $42.25M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $17.24M | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | ($18.01M) | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | ($35.28M) | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | ($21.05M) | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | ($69.49M) | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | ($71.84M) | Jun 29, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.80M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $6.80M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $20.82M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $21.08M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $8.70M | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | $8.70M | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | $8.70M | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | $8.70M | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | $8.70M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $8.70M | Jun 29, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($500.91M) | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | ($504.15M) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | ($482.40M) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | ($472.31M) | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | ($474.08M) | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | ($410.90M) | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | ($395.81M) | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | ($379.23M) | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | ($360.42M) | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | ($342.45M) | Jun 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $13.94M | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | $5.17M | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | $7.15M | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | $13.06M | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | $16.85M | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | $14.29M | Jul 30, 2021 |
| FY2020 | Mar 31, 2019 | $17.87M | Jul 6, 2020 |
| FY2019 | Mar 31, 2018 | $17.95M | Jul 16, 2019 |
| FY2018 | Mar 31, 2017 | $12.57M | Jun 26, 2018 |
| FY2017 | Mar 31, 2016 | $25.48M | Jun 29, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | (1) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | (1) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Jul 1, 2022 |
| FY2011 | Mar 31, 2012 | 0 | Jun 18, 2012 |
| FY2011 | Mar 31, 2011 | 0 | Jun 18, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 30, 2025 |
| FY2025 | Mar 31, 2024 | (1) | Jun 30, 2025 |
| FY2024 | Mar 31, 2023 | (1) | Jul 1, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jun 29, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Jul 1, 2022 |
| FY2021 | Mar 31, 2020 | 0 | Jul 30, 2021 |